Shares of Bio-Rad Laboratories, Inc. (NYSE:BIO.B – Get Free Report) gapped down prior to trading on Tuesday . The stock had previously closed at $341.00, but opened at $310.00. Bio-Rad Laboratories shares last traded at $310.00, with a volume of 104 shares.
Bio-Rad Laboratories Stock Performance
The company has a current ratio of 6.14, a quick ratio of 4.52 and a debt-to-equity ratio of 0.16. The firm’s fifty day moving average price is $333.49 and its 200 day moving average price is $325.90. The firm has a market capitalization of $9.77 billion, a PE ratio of -12.77 and a beta of 0.72.
Bio-Rad Laboratories Company Profile
Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.
Read More
- Five stocks we like better than Bio-Rad Laboratories
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- SAP’s Strong Momentum: A Bullish Setup for Investors
- Do ETFs Pay Dividends? What You Need to Know
- BlackRock Breaks Records: Why the Stock Still Has Room to Run
- ETF Screener: Uses and Step-by-Step Guide
- Duke vs. NRG: Which Energy Stock Will Power Higher Gains?
Receive News & Ratings for Bio-Rad Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Rad Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.
